Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 1.4 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-17 | 5.03 | 1.63 | 1.92p | 5.6 | n/a | n/a | n/a | 0.0% |
31-Dec-18 | 0.10 | (4.10) | (3.45)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | n/a | (4.79) | (3.53)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (17.73) | (9.46)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (57.86) | (24.28)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-22 | n/a | (25.70) | (11.80)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Grant of Options | 06-Jul-2022 | 07:00 | RNS |
Result of AGM | 30-Jun-2022 | 13:45 | RNS |
Second Price Monitoring Extn | 23-Jun-2022 | 16:40 | RNS |
AstraZeneca buys the rights to an asthma treatme... | 13-Jun-2014 | Daily Mail |
AstraZeneca in new £138million asthma drug deal | 13-Jun-2014 | Express & Star |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 25.00p |
Change Today | -1.80p |
% Change | -6.72 % |
52 Week High | 212.60 |
52 Week Low | 18.46 |
Volume | 153,127 |
Shares Issued | 201.37m |
Market Cap | £50.34m |
RiskGrade | 510 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:48 | 2,773 @ 25.21p |
16:35 | 2,770 @ 25.00p |
16:29 | 1,438 @ 25.80p |
16:29 | 1,762 @ 27.00p |
16:29 | 200 @ 26.76p |
CEO | Richard J Marsden |
Finance Director | John C Ward |
You are here: research